Figure 2.
The lectin-dependent function of mutant CALR is required for cytokine-independent growth, whereas its chaperone and polypeptide binding functionalities are dispensable. (A) Schema depicting mutations introduced into the lectin (dark red), polypeptide binding (blue), and chaperone (light green) domains of mutant CALR. (B) Immunoblotting of FLAG immunoprecipitated proteins from 293T cells cotransfected with wild-type CALR, mutant CALR, or mutant CALR lectin-, chaperone-, and polypeptide binding-deficient variants demonstrates that binding between mutant CALR and MPL is lost when residues required for lectin binding are mutated, but binding is retained when residues critical for CALR chaperone and polypeptide binding functionality are mutated. (C) Growth curves in Ba/F3-MPL cells expressing wild-type CALR, mutant CALR, or mutant CALR lectin- (left), chaperone- (center), and polypeptide binding-deficient (right) variants demonstrates that mutant CALR loses its ability to drive cytokine-independent growth when residues required for lectin binding are mutated but retains its ability to drive cytokine-independent growth in when residues critical for CALR chaperone and polypeptide-binding functionality are mutated. (D) In vitro binding assay between purified recombinant CALRWT or CALRMUT and purified recombinant ERp57 demonstrates that CALRWT binds directly to ERp57 but CALRMUT does not. (E) In vitro binding assay between purified recombinant CALRWT, CALRMUT, CALRMUT-D135L, or CALRMUT-D317A demonstrates that CALRMUT binds directly to MPL but not CALRWT or altered CALRMUT variants. (F) FLAG pulldown in 293T cells coexpressing CALRMUT and MPL glycosylation mutants (2xNQ = N117/178Q; 4xNQ = N117/178/298/358Q), shows CALRMUT binding to MPL-2xNQ but not to MPL-4xNQ.